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Phospholipids and sphingolipids play critical roles in signal trans-
duction, intracellular membrane trafficking, and control of cell
growth and survival. We discuss recent progress in the identi-
fication and characterization of a family of integral membrane
proteins with central roles in bioactive lipid metabolism and
signalling. These five groups of homologous proteins, which we
collectively term LPTs (lipid phosphatases/phosphotransferases),
are characterized by a core domain containing six transmembrane-
spanning α-helices connected by extramembrane loops, two of
which interact to form the catalytic site. LPT family members
are localized to all major membrane compartments of the cell.
The transmembrane topology of these proteins places their active
site facing the lumen of endomembrane compartments or the ex-
tracellular face of the plasma membrane. Sequence conservation
between the active site of the LPPs (lipid phosphate phosphatases),
SPPs (sphingosine phosphate phosphatases) and the recently iden-
tified SMSs (sphingomyelin synthases) with vanadium-depen-
dent fungal oxidases provides a framework for understanding their
common catalytic mechanism. LPPs hydrolyse LPA (lysophos-
phatidic acid), S1P (sphingosine 1-phosphate) and structurally-
related substrates. Although LPPs can dephosphorylate intracellu-
larly generated substrates to control intracellular lipid metabolism
and signalling, their best understood function is to regulate cell
surface receptor-mediated signalling by LPA and S1P by in-
activating these lipids at the plasma membrane or in the extra-
cellular space. SPPs are intracellularly localized S1P-selective
phosphatases, with key roles in the pathways of sphingolipid
metabolism linked to control of cell growth and survival. The SMS
enzymes catalyse the interconversion of phosphatidylcholine and
ceramide with sphingomyelin and diacylglycerol, suggesting a
pivotal role in both housekeeping lipid synthesis and regulation
of bioactive lipid mediators. The remaining members of the
LPT family, the LPR/PRGs (lipid phosphatase-related proteins/
plasticity-related genes) and CSS2s (type 2 candidate sphingo-
myelin synthases), are presently much less well studied. These
two groups include proteins that lack critical amino acids within
the catalytic site, and could therefore not use the conserved LPT
reaction mechanism to catalyse lipid phosphatase or phospho-
transferase reactions. In this review, we discuss recent ideas about
their possible biological activities and functions, which appear
to involve regulation of cellular morphology and, possibly, lipid
metabolism and signalling in the nuclear envelope.
Key words: lipid phosphatase, lysophosphatidic acid, phos-
pholipid metabolism, sphingolipid metabolism, sphingomyelin
synthase, sphingosine 1-phosphate.
INTRODUCTION
The realization that membrane lipids play critical roles in many
aspects of cell regulation is one of the most important advances
in biomedical research in the past 30 years. The identification of
many of the enzymes responsible for catalysing critical reactions
in pathways of bioactive lipid metabolism has often lagged behind
what continues to be steady and impressive progress in the defi-
nition of reactions and pathways responsible for the synthesis
and inactivation of bioactive lipids and their metabolites. This is
largely because the proteins responsible are often tightly asso-
ciated with cell membranes, making them difficult to isolate and
work with biochemically. Activity of these enzymes is character-
istically dependent on the physical form of their substrates, which
impedes the design and interpretation of in vitro assays to detect
and quantify them. This is a particular issue with assays using
detergent-solubilized substrates, which are a necessity when
working with enzymes that require membrane solubilization. The
identification of several important families of these lipid-meta-
bolizing enzymes has therefore most often resulted from a
combination of hard work, serendipity and ingenuity, rather than
the ‘traditional’ approach of protein sequencing, cDNA cloning
and, more recently, bioinformatics. The progress discussed in this
review began in the 1960s with the identification of membrane-
associated PA (phosphatidic acid) phosphatase activities [1,2],
and has culminated in the recent recognition that the enzymes
responsible for this activity, which are collectively termed LPPs
(lipid phosphate phosphatases) [3–6], belong to a larger family
of proteins that includes the SPPs (sphingosine phosphate phos-
phatases) [7,8], the long-sought animal SMSs (sphingomyelin
synthases) [9], as well as two groups of proteins, the LPR/PRGs
(lipid phosphatase-related proteins/plasticity related genes) [10–
13] and CSS2s (type 2 candidate sphingomyelin synthases) [9],
with less well-characterized enzymatic activities and functions.
IDENTIFICATION OF THE LPT (LIPID PHOSPHATASE/
PHOSPHOTRANSFERASE) FAMILY
Although the important role of LPPs in glycerophospholipid
metabolism and signalling had been long recognized and their
Abbreviations used: C1P, ceramide 1-phosphate; CPO, chloroperoxidase; CSS2, type 2 candidate sphingomyelin synthase; DG, diacylglycerol;
DPP, diacylglycerolpyrosphosphate phosphatase; EST, expressed sequence tag; G6P, glucose 6-phosphatase; LPA, lysophosphatidic acid; LPP,
lipid phosphate phosphatase; LPR/PRG, lipid phosphatase-related protein/plasticity-related gene; LPT, lipid phosphatase/phosphotransferase; PA,
phosphatidic acid; PC, phosphatidylcholine; PLD, phospholipase D; S1P, sphingosine 1-phosphate; SM, sphingomyelin; SMS, sphingomyelin synthase;
SPP, sphingosine phosphate phosphatase.
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activities characterized biochemically in some detail [14,15], dif-
ficulties in purifying the proteins responsible meant that these
enzymes were not characterized at a molecular level until 1996
[3,4]. Recognition of homologies between two Saccharomyces
cerevisiae open reading frames and a bacterial integral membrane
lipid phosphatase that dephosphorylates phosphatidylglycerol
phosphate [16], coupled with success in purification and sequenc-
ing of a mammalian LPP, revealed the existence of a family of
homologous enzymes in yeast and mammals with broad specifi-
city for lipid phosphates, including LPA (lysophosphatidic acid),
S1P (sphingosine 1-phosphate), PA, C1P (ceramide 1-phosphate)
and DGPP (diacylglycerol pyrophosphate) [3,4,6,17,18]. A
genetic screen in yeast subsequently identified two further homo-
logous proteins that were selective S1P phosphatases [19], and
mammalian homologues of these enzymes were identified by both
a complementation cloning approach and genome-wide sequence
analysis [8,20,21]. While progress in understanding the functions
of these mammalian LPP and SPP enzymes has continued steadily,
exciting advances in the past year have led to the identification
of three further groups of proteins that share the overall trans-
membrane topology of the LPPs and SPPs, but are characterized
by variations in the core catalytic domain sequence motifs that
define this family of proteins, and in the length and primary
sequence of the N- and C-terminal portions of the proteins that
flank the catalytic core. In this review, we collectively refer to this
multigene family of integral membrane enzymes as LPTs. One
group of these newly identified proteins, the SMSs, are mam-
malian homologues of the S. cerevisiae Aur1 gene product
that catalyse the reversible interconversion of PC (phosphatidyl-
choline) and ceramide with DG (diacylglycerol) and SM (sphin-
gomyelin) [9]. The other two groups of LPT family proteins
are presently much less well described. The first of these
have been termed LPR/PRGs. Two of the four LPR/PRG pro-
teins have a novel and unexpected role in regulation of cellular
morphology [10–12]. The final homology group of LPT
family proteins, provisionally termed CSS2s, have presently un-
characterized enzymatic activities and functions [9]. Figure 1
shows a dendrogram that illustrates the overall sequence similarity
relationships between the five classes of LPT proteins, noting a
more distant relationship of these proteins to G6P (glucose 6-
phosphatase), another integral membrane phosphatase enzyme
with a similar transmembrane topology and, as discussed in more
detail below, partial active site homology with the LPT family
proteins. Although the tissue distribution of RNA and protein has
been reported for some LPT family members [3,4,10,11,20,22],
the expression of these genes in mammalian cells and tissues has
not yet been examined in a comprehensive and systematic manner.
Analysis of the tissue distribution and relative abundance of ESTs
(expressed sequence tags) provides a useful and quantitative
way to evaluate gene expression patterns. Table 1 summarizes
extensive information regarding the expression pattern of all
members of the LPT family in adult human tissues compiled from
EST abundance data (http://www.ncbi.nlm.nih.gov/UniGene/).
Expression patterns of the individual genes are discussed below
in more detail in the corresponding sections of the article.
PRIMARY SEQUENCE AND TRANSMEMBRANE ORIENTATION
Figure 2 shows the proposed transmembrane orientation, topol-
ogy and structural organization of members of the LPT family.
These are all single polypeptide enzymes. Hydropathy analysis
identifies six regions of hydrophobic sequence that could form
transmembrane α-helices which are numbered 1–6. These helices
are linked by extramembrane loops numbered i–v. The lengths
of these loops vary between family members. This structurally
Figure 1 Primary sequence relationships between LPT family members
A dendrogram representing primary sequence homology relationships between members of the
LPT family is shown. The dendrogram was generated from a TCoffee alignment of the relevant
sequences using TreeView [94].
conserved core domain is flanked by N- and C-terminal exten-
sions. These extensions are also of varying lengths, and differ-
ences in the size and sequence composition of the N- and
C-termini are defining features of particular members of the five
classes of LPT proteins. This proposed transmembrane topology
has only been confirmed experimentally for LPP3 [23]. A pro-
tease-susceptibility study of the SMS enzymes indicates a cyto-
plasmic orientation of the C-terminus, which is also consistent
with this predicted topology [9]. The yeast and mammalian SPPs
and two of the LPR/PRG proteins have much longer C-termini
than all other LPT family members. Whereas the C-termini of the
LPR/PRG proteins are highly hydrophilic and are unlikely to form
additional membrane spans, the C-termini of the SPPs contain ad-
ditional hydrophobic sequences that, by hydropathy analysis, are
predicted to form two additional membrane-spanning α-helices,
denoted 7 and 8 in Figure 2 [8,19,21]. A recent examination of
the protease susceptibility of a series of epitope-tagged variants
of one of the yeast SPP enzymes demonstrated the presence of
these additional membrane helices [24], and it will be interest-
ing to determine if this topology is conserved in the mammalian
SPPs. Two other lines of evidence support the proposed transmem-
brane topology of the common core domain of these enzymes.
Firstly, some, but not all, family members contain a functional
glycosylation sequence in loop iii, implying that this region of the
proteins has access to the lumen of the endoplasmic reticulum and
Gogi apparatus as it traverses the secretory pathway [4,22,23].
Secondly, as discussed in detail in the following section, the
catalytic site of the enzymes is formed from three sequence
motifs, located in loops iii and v, and transmembrane sequences
that immediately precede these loop regions [16,25,26]. The
fact that these regions must be adjacent to each other to interact
to form the catalytic site of the enzymes also requires that
transmembrane helices 4–6 are oriented as shown in Figure 2. A
detailed study of the transmembrane topology and active site org-
anization of the integral membrane G6P is also consistent with a
c© 2005 Biochemical Society
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Table 1 Expression of LPT family proteins in adult human tissues
Expression profiles for the indicated genes were compiled from data available online at http://www.ncbi.nlm.nih.gov/UniGene/. The abundance of EST transcripts corresponding to each gene is
expressed as transcripts per million.
EST abundance (transcripts per million)
LPP SPP LPR/PRG SMS CSS2
LPP1 LPP2 LPP3 SPP1 SPP2 LPR1/PRG3 LPR2/PRG4 LPR3/PRG2 LPR4/PRG1 SMS1 SMS2 CSS2α CSS2β
Bladder 191 0 47 191 47 0 0 0 0 0 0 0 47
Bone 35 17 143 0 0 0 53 0 0 0 17 17 35
Bone marrow 27 0 136 54 0 0 0 27 0 109 27 0 27
Brain 107 30 166 35 19 48 181 17 124 48 13 45 24
Cervix 72 48 24 0 0 0 24 0 0 24 0 0 0
Colon 64 347 58 0 88 0 35 11 0 17 5 0 17
Eye 80 43 222 0 12 18 92 30 18 55 0 37 6
Heart 161 0 287 0 0 0 53 0 0 71 35 17 53
Kidney 172 44 202 37 112 29 7 0 0 44 14 7 37
Larynx 41 0 292 0 0 0 0 0 0 251 0 0 0
Liver 22 7 197 38 7 0 0 7 0 68 15 0 76
Lung 67 56 106 14 81 7 24 3 10 35 38 3 10
Lymph node 39 0 724 31 7 0 0 23 0 85 0 0 15
Mammary gland 132 24 490 0 33 0 41 0 0 57 33 0 8
Muscle 119 0 82 9 18 0 0 0 0 36 73 18 9
Ovary 63 116 21 0 31 10 116 10 0 31 10 21 21
Pancreas 74 211 161 0 12 0 87 12 0 12 37 0 0
Peripheral nervous system 318 0 238 0 39 0 159 0 0 119 0 39 0
Placenta 108 4 535 77 4 0 21 0 8 82 38 0 30
Pituitary – – – – – 0 38 0 0 46 7 – –
Prostate 483 38 576 7 15 0 42 0 – 12 0 31 23
Skin 30 12 6 24 24 0 0 0 0 0 0 0 6
Soft tissue 102 0 153 0 0 51 0 0 0 0 102 0 0
Spleen 0 0 0 0 0 0 0 0 0 120 0 0 0
Stomach 77 58 48 48 77 0 48 0 0 29 67 0 58
Tongue 36 0 36 0 145 0 0 0 72 109 0 0 0
Testis 60 7 68 7 15 7 7 15 15 83 30 0 30
Thymus 0 0 0 222 0 0 0 0 0 0 0 0 666
Uterus 196 156 214 0 17 0 11 5 0 57 34 0 17
Vascular system 154 0 656 0 38 0 0 0 0 308 38 0 0
Whole blood 105 0 39 13 13 0 52 26 0 66 0 0 0
functional interaction between catalytic residues located in loops
iii and v [27].
ACTIVE SITE STRUCTURE AND CATALYTIC MECHANISM
Shortly following the identification of the mammalian LPP and
yeast DPP (diacylglycerolpyrosphosphate phosphatase) genes,
three groups of workers noted that LPPs belong to a phosphatase
superfamily that is defined by a shared motif comprising three
separate sequences, denoted C1, C2 and C3, located in the third
and fifth extramembrane loops and proximal transmembrane
sequences [16,25,26]. This motif is conserved in the S. cerevisiae
DPPs, Escherichia coli phosphatidylglycerol phosphatase, and
mammalian G6Ps and SPPs. Figure 3 shows alignments of the
relevant catalytic domain sequences of all known mammalian
members of the LPT family. A critical insight, independently
noted by these investigators, was that this phosphatase motif is
also found in the active site of fungal oxyanion-dependent halo-
peroxidases. These enzymes share a common active site con-
figuration and reaction chemistry that has been best studied for
the vanadium-dependent CPO (chloroperoxidase) from the fungus
Curvularia inaequalis. This enzyme uses hydrogen peroxide to
catalyse the oxidation of halides to their corresponding hypo-
halous acids. Its three-dimensional structure has been solved at
atomic scale resolution [26]. The active site of CPO is formed
from four α-helices linked, on one face, by short polypeptides
containing the phosphatase-consensus motif sequences. Prompted
by the observation that the active site of CPO is homologous
with that of the integral membrane phosphatases, CPO was also
shown to be a broad specificity phosphatase with activity against
p-nitrophenol phosphate and several other synthetic substrates
[28]. High-resolution structural information, coupled with muta-
genesis and measurements of enzymatic activity, as well as spec-
troscopic studies of oxyanion binding to CPO isoforms from
several fungi, indicated that the trigonal bipyrimidal vanadate
cofactor required for the halide oxidation reaction interacts with
the enzyme in the same manner as the transition state phos-
phate intermediate of the phosphatase reaction. The C3 histidine
and aspartic acid residues operate as a charge-relay system in
which the histidine residues acts as a nucleophile, driving form-
ation of a phosphohistidine intermediate. The C2 histidine facili-
tates phosphate bond cleavage and participates in the second step
of the reaction in which the phosphohistidine intermediate is
hydrolysed, freeing the active site for another round of catalysis.
The invariant lysine, arginine, serine and glycine residues of the
C1, C2 and C3 regions donate hydrogen bonds to the phosphate
oxygen molecules and stabilize the transition state of the reaction
(Figure 4) [26,28–30]. Although no structures are presently
available for any of the integral membrane phosphatase/phospho-
transferases, this detailed information about the catalytic mech-
anism of CPO provides an experimentally validated framework
for understanding how the LPP and SPP enzymes catalyse hydro-
lysis of their substrates [31–33], and indicates how the SMS
enzymes have probably adapted this reaction chemistry to
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Figure 2 Structural organization of LPT family members
(A) Diagram illustrating the transmembrane topology of members of the LPT family. (B) Diagram
illustrating the structural organization of members of the LPT family.
perform a phosphotransferase reaction [9]. The incomplete con-
servation of the phosphatase active site in the LPR/PRG proteins
and in one of the CSS2 proteins implies that they could not cata-
lyse a phosphatase reaction using this mechanism [9–12].
LPPs
Structural organization and enzymology
LPPs are the prototypic members of the LPT family. The three
mammalian enzymes, LPP1–LPP3, catalyse divalent cation ion-
independent hydrolysis of lipid phosphomonoesters [3,4,6] and
can also perform complete dephosphorylation of diacylglycerol-
pyrophosphate, indicating that they have phosphodiesterase
activity against a pyrophosphate bond [34]. However, they will
not cleave the phosphodiester bond of glycerophospholipids.
Although there are modest differences in Vmax and interfacial
Km values when analysed using a mixed micellar assay system,
LPPs hydrolyse a range of lipid phosphomonoesters, which in-
cludes LPA, PA, S1P and C1P, with broadly similar activities
[6,14]. They do not hydrolyse the phosphomonoester groups
of the phosphoinositides PtdIns(4)P and PtdIns(4,5)P2, and will
not hydrolyse soluble substrates such as glycerol 3-phosphate.
Although LPPs can hydrolyse substrates in complex with BSA
[6] and are clearly enzymatically active in biological membranes
and when reconstituted into artificial lipid bilayers [35], they are
markedly more active against substrates dispersed in non-ionic
detergents, particularly Triton X-100 [6,14]. The invariant amino
acids of the C1, C2 and C3 phosphatase motif are completely
conserved in these mammalian LPP enzymes, and mutagenesis
studies of S. cerevisiae DPP1, LPP1 and LPP3 indicate that their
catalytic mechanism is identical with that demonstrated for CPO
[32,33,36]. The issue of what makes these enzymes broadly
specific for lipid phosphate substrates in comparison with the
SPP and SMS enzymes, which are highly selective (see below), is
presently unresolved. As discussed below, the SPPs also contain a
completely conserved C1-C2-C3 phosphatase motif with a minor
substitution in the C2 sequence (Ser-Thr-His instead of Ser-Gly-
His, Figure 3), yet these enzymes appear to be absolutely selective
for S1P [37]. The possibility that this simple substitution in the C2
sequence accounts for this dramatic difference in substrate speci-
ficity is an interesting, but, as yet, untested idea.
Expression, localization and functions
LPP1 and LPP3 are widely expressed in human tissues, whereas
levels of LPP2 transcripts are somewhat lower and more re-
stricted. However, the majority of tissues examined express all
three genes (Table 1), and these results are broadly consistent
with the published analyses of LPP RNA distribution and,
in cases where appropriate antibodies are available, protein
expression [3,4,17,22]. cDNAs encoding apparent splice variants
of LPP1 and LPP2 with alternative N-terminal sequences and
truncated C-termini have been deposited in GenBank® [38]. Two
of these cDNAs encode proteins without a complete catalytic
domain. It is presently not known if proteins corresponding to
these variant cDNAs are actually expressed, so the significance
of these findings remains unclear. The subcellular localization of
LPPs has been examined in a number of different cell types
by overexpression of epitope-tagged variants, or, in a smaller
number of cases, endogenously expressed LPPs have been visual-
ized by indirect immunofluorescence using selective antibodies
[18,22,39,40]. The proteins predominantly localize to the endo-
plasmic reticulum and plasma membrane, with possible local-
ization to other endomembrane compartments, including the
Golgi apparatus and endosomes also being noted. Increases in
intact cell lipid phosphatase activity against exogenously applied
substrates observed in cells overexpressing LPP1 and LPP3
are also consistent with localization to the plasma membrane
[18,35,41]. Biochemical fractionation experiments indicate that
LPP1 and LPP3 exhibit cell-specific localization to detergent-
resistant membrane domains, which are considered to represent
lipid rafts or caveolae [22,42]. Recruitment of LPPs to these
membrane domains may be an important way to compartment-
alize them with LPA or S1P receptors or with lipid signalling
enzymes, particularly PC-specific PLD (phospholipase D) en-
zymes which are also found in caveolae and raft domain mem-
branes [43].
Two major functions have been proposed for the LPPs. Firstly,
they have been suggested to have roles in regulation of intra-
cellular lipid metabolism by controlling the balance between PA
and DG with obvious consequences for both cell signalling and in-
fluence on the synthesis of choline- and inositol-containing phos-
pholipids. Although overexpression of LPP1 [39,44–46] and
overexpression [22] or knock-out [36] of LPP3 clearly have effects
on intracellular lipid metabolism in some, but not all, cells, the
mechanism and significance of these observations remain largely
unexplored. In this regard, perhaps the most interesting possible
function for LPPs in intracellular lipid metabolism and signalling
involves hydrolysis of PA generated by PLD. In this situation,
LPP activity would terminate PLD signalling by hydrolysis of
PLD-generated PA, concurrently forming DG which could activ-
ate lipid-responsive protein kinase C isoforms. In support of this
idea, overexpression of LPP3 was shown to enhance PLD-depen-
dent production of DG, possibly as a result of co-localization
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Figure 3 Catalytic domain sequence conservation among LPT family members
Alignment of catalytic domain sequences of members of the LPT family with cognate sequences from a fungal haloperoxidase (CPO), bacterial phosphatidylglycerol phosphatase (PgpB), yeast DPP1
and human G6P. H. sapiens, Homo sapiens.
of LPP3 with a specific PLD isoenzyme, PLD2, in detergent-
insoluble lipid raft domains [22]. Similarly, the Raf protein ki-
nase appears to be a signalling target of PLD-generated PA and
overexpression of LPP1 and LPP2 attenuates activation of the
downstream Raf effector MAPK (mitogen-activated protein kin-
ase) by stimulation of G-protein-coupled cell surface receptors
[39]. Secondly, by virtue of their localization to the plasma
membrane in many cell types [6,18,22,35,40,47] and their demon-
strated ability to function as ecto-enzymes that dephosphorylate
bioactive lipids with receptor-directed signalling actions, such as
LPA and S1P [6,18,35,48], LPPs have been proposed to function
as negative regulators of receptor-directed signalling by these bio-
active lipid mediators. Experimental data, based in large part on
overexpression studies and to a lesser extent on loss of function
experiments using antisense RNA and pharmacological inhibitors,
support this idea. The role of LPPs in regulation of signalling
by cell surface lysophospholipid receptors has been reviewed ex-
tensively by others [13,38,49,50] and will not be discussed further
here.
LPP3 knock-out mice exhibit defects in patterning during
early development
It is perhaps more interesting that attempts to ascribe functions
to the mammalian LPPs at a cellular and organismal level are
beginning to reveal unexpected functions, some of which may
not directly involve their catalytic activities. The broad and over-
lapping expression patterns of the three LPPs (Table 1) suggests
that their functions may be non-redundant and consistent with
this idea; mice lacking LPP2 are viable and were reported to ex-
hibit no overt phenotype [51]. Inactivation of LPP1 in mice has
not yet been reported. However, transgenic overexpression of
LPP1 under control of a ubiquitously active actin promoter pro-
duced a runted phenotype with defects in spermatogenesis and
fur growth. Circulating levels of LPA in the blood of these ani-
mals were not different from those measured in wild-type mice,
and their phenotype was suggested to result from effects on the
intracellular accumulation of DG which was observed in LPP1-
overexpressing cell lines derived from these animals [46]. In
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Figure 4 LPT reaction mechanism
A representation of the catalytic mechanism of LPT family members, highlighting functions for the conserved residues of the C1, C2 and C3 sequences of conserved catalytic motif in the reaction
chemistry.
marked contrast with the relatively benign effects of manipulating
LPP1 and LPP2 expression in mice, homozygous inactivation
of the murine LPP3 gene results in early embryonic lethality
and a complex phenotype characterized by defects in both vas-
culogenesis and patterning during early development [36]. The
duplication of axis symmetry observed in embryos from LPP3
null mice is similar to that observed when the Wnt signalling
pathway is activated, for example, by ectopic embryonic over-
expression of Wnts [52]. This phenotype also results from
inactivation of axin which is a scaffolding protein functioning
as a negative regulator of Wnt signalling by binding activated
β-catenin [53]. Experiments using cells derived from LPP3
null mice reveal a novel role for LPP3 as a negative regu-
lator of the Wnt signalling pathway. Expression of a Wnt reporter
gene construct was higher in LPP3 null cells than in wild-type
cells, whereas ectopic expression of LPP3 in LPP3 null cells
reduced Wnt signalling activity to wild-type levels and con-
currently reduced nuclear translocation of β-catenin [36]. The
mechanism by which LPP3 inhibits Wnt signalling is currently not
known. In addition to the ‘cannonical’ Wnt signalling pathway,
Wnts also activate a phospholipase C-coupled pathway, leading to
protein kinase C activation [54]. Overactivation of this ‘Wnt/Ca2+’
pathway results in attenuation of the cannonical Wnt signal-
ling pathway and a ventralizing phenotype [55], which is very
similar to that seen when mammalian LPP3 was ectopically ex-
pressed in Xenopus embryos [36]. As noted above, overexpression
of LPP3 has been shown to result in increased levels of DG in
cells [22], and DG levels were decreased in LPP3 null cells with
a concurrent decrease in activated protein kinase C, which might,
in turn, result in a stimulation of the canonical Wnt signalling
pathway. On the other hand, studies using catalytically inactive
LPP3 mutants indicate that the ability of overexpressed LPP3 to
suppress Wnt signalling in LPP3 null cells is, at least partially,
independent of enzymatic activity, implying the involvement of
an alternative, as yet unidentified, mechanism [36]. Although
overexpression of a catalytically inactive mutant of LPP1 has
been shown to attenuate LPA-stimulated cytokine secretion in
bronchial airway cells [41], the only ‘non-enzymatic’ function
suggested for LPP3 is regulation of cell–cell interactions by an
integrin-binding RGD (Arg-Gly-Asp) sequence present in the
third extramembrane loop [56]. Although this finding is pro-
vocative in light of the involvement of LPP3 in Wnt signalling,
which can also be regulated through another cell surface-adhesion
molecule, p120 catenin, its broad relevance for mammalian LPP3
function is questionable, because the cognate sequence in murine
LPP3 is RGE (Arg-Gly-Glu), which would not be expected to
bind integrins.
Drosophila LPPs regulate germ cell migration and survival during
early development
Studies in Drosophila have identified roles for two LPP homo-
logues, the products of the wunen genes wun and wun2, in
regulation of embryonic germ cell migration and survival [57–59].
Drosophila germ cells form at the posterior pole of the developing
embryo and are swept into the hindgut and posterior midgut during
gastrulation. The germ cells then move across the midgut, re-
orient dorsally and migrate into the mesoderm to associate with
the somatic gonadal precursor cells [59–61]. wun and wun2 act
redundantly as repellant factors to guide migrating germ cells in
the Drosophila embryo. These genes are normally expressed
in somatic tissues that the germ cells avoid. However, in wunen
mutants, in which both genes are disrupted, the germ cells
scatter throughout the embryo, failing to reach the mesoderm and
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eventually dying. By contrast, overexpression of wun or wun2 in
somatic tissues, such as the midgut and mesoderm, that normally
attract germ cells, results in germ cell repulsion and death
[57,59]. The repulsive effect of these LPPs on germ cell migration
has been suggested to be a result of their ability to degrade a
lipid factor that both guides germ cells and serves as a germ
cell survival factor during their migration in the developing gut.
However, whereas both wun and wun2 are functional LPPs
whose enzymatic activity is necessary for their ability to repel
germ cells [59,62], the chemical identity of this lipid signal has
not yet been determined. The finding that mammalian LPP3
can also repel germ cells when expressed in the somatic cells
of Drosophila embryos indicates a conserved function between
insect and mammalian LPPs, although surprisingly mammalian
LPP1 cannot repel germ cells in this assay [62,63]. The basis for
this difference in biological activity between LPP3 and LPP1 is
not known. Although their substrate specificities and enzymatic
activites are very similar in vitro, these two LPPs have been shown
to localize selectively to the apical and basolateral surface of
polarized cells [40], and LPP3 has also been reported to localize
to detergent-resistant membrane domains [22], so it is possible
that differences in subcellular localization or, perhaps, regulation
of these LPPs, rather than in their intrinsic enzymatic activity or
substrate selectivity, accounts for their distinct effects on germ cell
migration when expressed in Drosophila embryos. Interestingly,
wun and mammalian LPP1 and LPP3 were recently shown to form
stable homodimers through interactions requiring the C-termini
of the proteins in overexpression experiments conducted using
epitope-tagged proteins [63a]. Although, at least in the case of
wun, this interaction did not appear to have functional relevance,
these findings raise the possibility that interactions between LPPs
may modulate their localization or activities in some settings [62].
A new study identifies a novel and surprising additional role
for wun2 as a germ cell-specific factor required for proper germ
cell migration and survival [63]. wun2 is specifically expressed in
germ cells of the developing Drosophila embryo from maternally
inherited RNA. Expression of catalytically active wun2 in germ
cells is required for germ cell survival in otherwise wild-type
embryos and, as in the germ cell repulsion assays described above,
when expressed in germ cells, LPP3 can substitute for wun2. Germ
cell-specific expression of wild-type, but not catalytically inactive
alleles of Wun2 or of mammalian LPP3, could suppress germ
cell death resulting from somatic overexpression of wun2. wun2
therefore exhibits paradoxical cell- and tissue-specific effects on
germ cell survival. When expressed in germ cells, wun2 promotes
their survival, whereas expression of either wun2 or wun in
somatic cells repels migrating germ cells and promotes germ
cell death. Experiments in which expression levels of wun2 in
germ cells or somatic cells were separately regulated revealed
a reciprocal relationship between the actions of wun2 in germ
cells and somatic cells. Germ cell death induced by somatic over-
expression of wun2 could be suppressed by overexpression of
wun2 in germ cells, whereas germ cell death resulting from a
lack of maternally expressed germ cell wun2 could be rescued by
reducing somatic wun2 expression. These results suggest a model
in which somatic wun and wun2 compete with germ cell wun2
for a common lipid substrate. While hydrolysis of this substrate
in the soma results in decreased germ cell survival, hydrolysis
of the substrate by germ cells promotes their survival. As noted
above, both wun and wun2 are active LPPs with substrate specifi-
cities and catalytic properties that are very similar to those of
the mammalian LPPs [62,63]. As was observed for mammalian
LPP1 [35], overexpression of wun2 in cultured insect cells
results in a significant enhancement of cellular accumulation of
lipid dephosphorylation products when the cells are incubated
with fluorescent analogues of PA [63]. Hydrolysis-coupled intra-
cellular accumulation of PA dephosphorylation products has
been described in mammalian cells [64,65]. This phenomenon
may involve partitioning of the lipid substrate into the plasma
membrane where LPP-catalysed hydrolysis generates a non-polar
lipid product, DG, that can enter the cell by endocytosis where
it becomes susceptible to further metabolism. It is therefore
plausible that, although the activities of wun and wun2 in the soma
may be linked to degradation of a pool of a lipid phosphate
substrate that is required for germ cell guidance and survival,
the germ cell-specific action of maternally inherited wun2, which
is necessary for germ cell survival, is linked to wun2-facilitated
lipid uptake and the intracellular accumulation of a bioative lipid
signalling molecule. In light of the apparent absence of G-pro-
tein-coupled lysophospholipid receptors from the Drosophila
genome [66,67], it is possible that the ability to facilitate lipid
uptake might represent a primary signalling function for wun
and/or wun2. Clearly, the identification of the relevant lipid
substrate hydrolysed by wun/wun2 in the somatic and germ
cells of Drosophila embryos remains a major challenge. The
possibility that mammalian LPPs also have signalling functions
that are coupled to the intracellular accumulation of lipid dephos-
phorylation products is also an area worth examining further.
SPPs
Structural organization and enzymology
The identification of the mammalian SPPs was preceded by
studies of yeast genes that encode enzymes that dephosphorylate
phosphorylated sphingoid bases and are named YSR3/LBP2
and YSR2/LBP1/LCB3 [19]. These yeast enzymes are non-
redundant and both exhibit high phosphatase activity against
long-chain sphingoid base phosphates. Although SPP1 has been
characterized in most detail, in contrast with the broad specificity
of LPP1–LPP3 for lipid phosphomonoester substrates, SPP1
and 2 are highly selective for S1P [20,37]. Another notable
difference between the LPP and SPP enzymes is that, whereas the
LPPs are most active against detergent-solubilized substrates,
the SPPs are inhibited by detergents and show a marked prefer-
ence for substrates that are bound to a protein carrier [8,68].
As noted above, SPPs contain a consensus phosphatase/phospho-
transferase catalytic motif with a minor substitution in the C2
sequence, but, in contrast with the LPPs, their C-terminus is much
longer and may contain an additional two transmembrane spans.
Expression, localization and functions
SPP1 and SPP2 have broad and partially overlapping expression
patterns in mammalian tissues. Expression of SPP2 appears more
widespread than SPP1 [20] (Table 1). Like the LPPs, it has
proven difficult to generate effective antibodies against mam-
malian SPPs, so overexpression studies using epitope-tagged
proteins have been used to investigate their subcellular
localization. In contrast with the LPPs which are broadly local-
ized to both endomembrane compartments, primarily the endo-
plasmic reticulum, and to the plasma membrane, SPP1 and SPP2
are restricted to the endoplasmic reticulum [20,37], which is
similar to the subcellular localization of their yeast counterparts
[69]. Ideas about the function of these enzymes therefore empha-
size the possibility that they have roles in intracellular sphingo-
lipid metabolism, in particular generation of sphingosine for
ceramide synthesis, rather than a primary direct role in the in-
activation of S1P at the cell surface and consequent termination of
its signalling actions, which, as discussed above, is a more likely
potential function for the LPPs. The most detailed information
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about SPP function comes from studies in yeast, which are now
being extrapolated to mammalian cells. Yeast sphingolipids are
structurally analogous to mammalian sphinoglipids, except that
the polar head group is phosphoinositol, whereas phytosphingo-
sine is the predominant sphingoid base, as opposed to choline
and sphingosine respectively. Yeast sphingolipids, in particular
ceramide, have well-defined functions in protection from heat,
osmotic and low pH stresses [70]. Deletion of LBP1 and LBP2
results in a marked accumulation of phosphorylated sphingoid
bases, a concomitant reduction in ceramide levels and a dramatic
increase in resistance to these stresses. Conversely, overexpression
of LBP1 results in ceramide accumulation and increased
sensitivity to stress [19]. Mutational analysis and suppressor
screens demonstrate that LBP1p functions to control the balance
between sphingoid bases, which are used for sphingolipid syn-
thesis, and phosphorylated sphingoid bases, which are recycled
for phospholipid synthesis. Interestingly, LBP1 mutants are also
unable to incorporate exogenously supplied sphingosine into
sphingolipids, which suggests that phosphorylation and dephos-
phorylation of these lipids is somehow required for their use
as precursors for ceramide synthesis [70,71]. Studies in mam-
malian cells reveal an analogous role for SPP1 in control of
ceramide levels and apoptosis, but suggest additional roles for
the mammalian SPPs in control of sphingolipid metabolism and
signalling.
SPPs regulate survival, apoptosis and migration
in mammalian cells
Forced overexpression of SPP1 in HEK-293 cells results in
significantly increased levels of intracellular ceramide. This
SPP1-dependent increase in ceramide levels can be enhanced
further by exogenous application of S1P that presumably enters
the cells and is dephosphorylated by SPP1 at the endoplasmic
reticulum to generate sphingosine, which in turn serves as
a substrate for ceramide biosynthesis [72]. In mammalian
cells, a substantial body of evidence identifies ceramide as an
intracellular signal for stress-induced apoptosis [73]. The
increased levels of ceramide observed in SPP1-overexpressing
cells were associated with reduced cell survival and increased
apoptosis [8,72]. A curious observation from these experiments
was that, although an equally good substrate for SPP1, exogenous
application of dihydroS1P had no effect on intracellular
ceramide levels or apoptosis. These interesting findings imply
different roles for ceramide and dihydroceramide in sphingolipid
synthesis and regulation of apoptosis, possibly related to
trafficking of ceramide and dihydroceramide between different
endomembrane compartments that serve as sites for the syn-
thesis and actions of these lipids [68,72]. Although mouse
knock-out models of SPP1 have not yet been reported, RNA
interference studies conducted in mammalian cells reveal a role
for SPP1 in control of levels of S1P, both within cells and extra-
cellularly, and suggest an addition mechanism by which SPP1
could regulate apoptosis. Knock-down of SPP1 resulted in sig-
nificant accumulation of both intra- and extra-cellular S1P, sug-
gesting that SPP1 activity normally opposes the synthesis of S1P
by sphingosine kinase. Suppression of SPP1 expression in these
cells rendered them resistant to apoptosis induced by TNF (tumour
necrosis factor) and chemotherapy drugs [21]. Through actions
mediated by specific G-protein-coupled cell surface receptors,
S1P is a potent and effective survival factor for many mammalian
cells [67], so it is reasonable to postulate that the resistance to
apoptosis observed when SPP1 expression is suppressed results
from an enhancement of S1P signalling [21]. These results raise
the possibility that the increases in apoptosis associated with
overexpression of SPP1 may result from a decrease in S1P levels,
rather than increases in ceramide levels as suggested above. These
competing ideas are not mutually exclusive and clearly this issue
will require further experimentation to resolve. For example, one
critical consideration is that the extracellular levels of S1P that
result in increased intracellular accumulation of ceramide are
much higher than the levels required to promote cell signalling
responses through actions mediated by S1P receptors. It is also
unclear if these effects on intracellular sphingolipid metabolism
are restricted to the SPPs or if overexpression of one or more
of the LPPs, which can both dephosphorylate S1P and localize
to the endoplasmic reticulum in many cells, can also increase in-
tracellular levels of ceramide or regulate levels of S1P inside and
outside of cells. It is also important to note that all of these studies
have focused on SPP1 and, although it is clearly an active S1P




The sole pathway for SM synthesis in mammalian cells involves
the enzymatic transfer of the phosphocholine group of PC to
ceramide, generating SM and DG [74]. The enzyme responsible,
SMS, therefore occupies a central position at a crossroads of
sphingolipid and phospholipid metabolism. The actions of this
enzyme not only generate sphingomyelin, but also regulate
cellular levels of the signalling lipids DG and ceramide [73,75].
However, despite the pivotal role of this membrane-associated
activity in both phospho- and sphingo-lipid metabolism, the
enzymes responsible for this reaction in mammalian cells were
only identified very recently. Studies published in the past year
have described a family of two animal SMSs termed SMS1
and SMS2 [9]. These are integral membrane proteins that, as
discussed in detail above, have the common six transmembrane-
spanning core domain topology that is common to the LPT family.
SMS1 and SMS2 contain the C2 and C3 catalytic motifs which
are likely to be responsible for the phosphotransferase step of
catalysis, whereas the C1 motif is absent and replaced by unique
SMS-specific sequence motifs that are likely to be responsible
for substrate recognition and orientation in the active site [9] (Fig-
ures 2–4). SMS1 and SMS2 were identified using a candidate gene
expression cloning strategy. The essential S. cerevisiae Aur 1
gene product catalyses the transfer of the headgroup of phosphat-
idylinositol to phytoceramide, generating inositol-phosphoryl-
ceramide and DG [76,77]. BLAST searches for novel sequences
encoding integral membrane proteins containing the C2 and C3
domain common to Aur1p and LPPs without homologues in
yeast or previously characterized biochemical functions identified
three groups of candidate genes with homologues in multiple
animal species. Epitope-tagged variants of these proteins were
expressed in yeast, and SMS activity was determined in vitro
using membrane extracts as a source of activity by monitoring
the incorporation of fluorescent ceramide into SM which proceeds
using endogenous membrane PC as a substrate. Two of the human
proteins tested, SMS1 and SMS2, were active in these assays.
SMS activity could be observed using exogenously provided
PC, but not lyso-PC, choline, phosphorylcholine or nonphos-
phocholine lipids, including phosphatidylethanolamine, suggest-
ing that the enzyme recognizes the two acyl chains attached
to the phosphocholine headgroup. Interestingly, in these experi-
ments, SM itself could also serve as a headgroup donor, indicating
that, as observed previously using membrane preparations as a
source of enzyme activity [78], the SMS reaction is reversible.
A subsequent publication reported expression cloning of SMS1
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using an equally elegant complementation strategy employing
mammalian cell lines with previously described defects in SMS
activity. This study is of importantance as it demonstrated
that SMS1 is functional when expressed in intact cells [79].
As noted above and consistent with the presence of SM in
many organisms, SMS homologues are found in many species.
Drosophila, which lacks SM, but instead synthesizes
ethanolamine phosphoceramide, is a notable exception. Although
the Drosophila genome does not contain SMS homologues, a
single SMS-related gene was identified that might encode an
ethanolamine phosphotransferase responsible for ethanolamine
phosphoceramide synthesis [9].
Localization and function
Prior to the identification of the SMS genes, fractionation studies
suggested that SMS activity was associated with both the Gogi
apparatus and plasma membrane [80,81]. In agreement with
these findings, indirect immunofluorescence analysis of epitope-
tagged SMS1 and SMS2 in HeLa cells revealed two distinct
localization patterns. SMS1 was mainly found at the Golgi ap-
paratus, whereas SMS2 displayed a predominantly plasma mem-
brane localization and only partial co-localization with the Golgi
marker sialyltransferase. The C-terminally appended V5 epitope
tag of SMS2 was insensitive to proteolysis when trypsin was
added to intact cells, but could be readily degraded when the
plasma membrane was permeabilized with detergent. This finding
implies that, as is the case with other LPT family members, the
C-termini of SMSs are oriented towards the cytosol, whereas
the active sites are directed towards the lumen of the Golgi
apparatus or the extracellular space [9]. The orientation and
localization of SMSs suggest that SMS1 may have a primary
‘housekeeping’ role in SM synthesis within the cell, whereas
SMS2 could have a lipid signalling function at the plasma mem-
brane, possibly working in conjunction with sphingomyelinases
to regulate plasma membrane levels of the pro-apoptotic sig-
nalling lipid ceramide. Nothing is presently known about how
SMS1 and SMS2 activity is regulated. In light of the reversibility
of the SMS reaction, it is possible that the relative concentrations
of DG and ceramide resulting from the actions of phospholipases
C and sphingomyelinases in the vicinity of SMS are a relevant
determinant of the direction and rate of the SMS reaction. In this
regard it is interesting to note that up- and down-regulation of SMS
activity has been linked to mitogenic and pro-apoptotic signalling
in several mammalian cell types [73]. The identification of SMS1
and SMS2 provides unique tools to investigate the regulation and
functions of these long-sought enzymes.
LPR/PRGs
Structure and enzymology
In comparison with other members of the LPT family, the four
members of the LPR/PRG family are characterized by incomplete
conservation of the C1, C2 and C3 catalytic motif sequences. As
mentioned above and illustrated in Figure 3, these proteins share
a non-conservative substitution of the C3 nucleophilic histidine
residue and of the C1 lysine and arginine residues, and there
are additional non-conservative substitutions of the C2 motif
residues in some LPR/PRG family proteins. The proposal that
these genes are named LPR proteins [12,13] was intended to
reflect this incomplete structural relationship to the LPPs and
other LPT family members. One of these genes, LPR3, was cloned
from a rat brain cDNA library and given the name PRG1 to
reflect the regulation of its expression during brain development
and response to experimentally induced hippocampal lesions
[10]. In agreement with this nomenclature, the other members
of this gene family have been termed PRG2, PRG3 and PRG4
[11]. The LPR nomenclature has been adopted by GenBank®,
because of the pre-existing use of the acronym ‘PRG’ for an
unrelated family of secreted proteoglycan genes [82]. For clarity
and consistency, we refer to LPR/PRG proteins in the present
article. Ideally, this imprecise terminology will soon be replaced
by a nomenclature that reflects the biological functions of these
proteins. The incomplete conservation of the catalytic motif in
all of the LPR/PRG proteins, and, in particular, the non-conser-
vative substitution of amino acid residues that are critical for
catalysis in other LPT family members, implies that none of the
LPR/PRG proteins could catalyse lipid phosphatase or phospho-
transferase reactions using the mechanism discussed in detail
above (Figures 3 and 4). Consistent with this prediction, the
LPR/PRG proteins do not have SMS activity when expressed in
yeast [9], and two of these proteins, LPR1/PRG3 and LPR3/PRG1
do not have LPA phosphatase activity when expressed in HEK-
293 cells and assayed using either intact cells or cell membranes
as the source of enzyme activity [12]. These experiments were
conducted using a highly sensitive ‘phosphate-release’ assay
with 32P-labelled substrates, or a less sensitive assay in which
the formation of radiolabelled monoacylglycerol by hydrolysis
of acyl chain labelled LPA substrate was monitored under
conditions where activity of a co-expressed LPP could be readily
detected. Both the LPR/PRG proteins and the control LPP
protein were expressed to similar levels, as shown by Western
blotting using antibodies against an appended C-terminal tag. In
accordance with these findings, overexpression of LPR1/PRG3
in a cultured neuronal cell line did not result in increases in
the rate of hydrolysis of exogenously added LPA by intact cells
[11]. Paradoxically, however, overexpression of LPR3/PRG1 has
been reported to result in variable increases in rates of LPA
hydrolysis (either 5-fold or 2-fold compared with the control)
in the same neuronal cell line [10,11]. Given the inactivity of
LPR3/PRG1 in more carefully controlled experiments, if these
observations can be substantiated by others, one explanation may
be that overexpression of LPR3/PRG1 in some cells results in
an upregulation of the activity of endogenously expressed LPPs
at the cell surface. As discussed in more detail below, resolution
of this issue is critical to our understanding of the biological
activities of these LPR/PRG proteins. The other noteworthy
structural feature of the LPR/PRG proteins is the very long C-
terminus (approx. 400 amino acids) found in LPR3/PRG1 and
LPR4/PRG2, which is unique among the entire LPT family. This
region of the proteins is highly enriched in charged amino acid
residues and contains PEST (Pro-, Glu-, Ser- and Thr-containing)
sequences that, in other proteins, function as signals for ubiqutin-
dependent targeting for proteolytic degradation [83]. Multiple
species of C-terminally tagged LPR3/PRG1 are detected when
the protein is overexpressed in mammalian cells, suggesting that
proteolysis may be a highly relevant mechanism for regulation
of the turnover and expression levels of the protein [12]. In-
spection of both EST sequences and genomic sequences for
LPR3/PRG1 and LPR4/PRG2 provides evidence for the existence
of splice variants with alternative C-termini, which may provide
an additional mechanism for regulating the biological activities
of these proteins.
Expression, localization and functions
In contrast with the LPPs and SPPs, the individual members of
the LPR/PRG family exhibit much more restricted expression
patterns. Northern blot analysis showed that LPR3/PRG1 was
most strongly expressed in the brain, although weaker expression
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in peripheral tissues was also apparent, which is consistent with
the tissue distribution of corresponding ESTs with transcripts
found in the eye, kidney and ovary [10]. LPR4/PRG2 is more
widely expressed than LPR3/PRG1. Similarly, LPR1/PRG3 ex-
hibits a more restricted expression pattern than LPR2/PRG4
(Table 1). The distinct and, in many cases, non-overlapping ex-
pression patterns of the LPR/PRG genes suggests that they may
not function redundantly. The characterization of the LPR/PRG
proteins is at an early stage. Overexpression of wild-type LPR3/
PRG1, but not of an LPR3/PRG1 mutant containing a non-con-
servative substitution of one amino acid residue that is conserved
within the LPT C2 catalytic motif and known to be critical for
catalysis in the LPPs, was reported to protect cultured neuronal
cells from the neurite-collapsing actions of exogenously applied
LPA. In conjunction with the finding that neuronal expression
of LPR3/PRG1 is increased during brain development, and re-
generative sprouting of axons and neurites induced in response to
hippocampal injury, these observations were suggested to identify
a normal role for LPR3/PRG1 as a regulator of these kinds of
neuronal membrane protrusions during brain development and
responses to injury through the localized attenuation of LPA sig-
nalling [10]. Clearly identification of the mechanism by which
overexpression of LPR3/PRG1 apparently increases rates of
dephosphorylation of exogenously provided LPA is of critical
importance to understanding this phenomenon. More importantly,
this suggestion implies that endogenously-formed LPA has a
normal role in regulation of neuronal plasticity, which is an inter-
esting, but as yet unproven, idea [84,85]. Further testing of these
interesting ideas regarding LPR3/PRG1 function will require
loss-of-function approaches and the identification of the LPA
receptors responsible for these putatively LPR3/PRG1-regulated
signalling pathways. In apparent contrast with these effects of
the overexpression of LPR3/PRG1 on neurite outgrowth, over-
expression of LPR1/PRG3 was reported to cause the spontaneous
outgrowth of structures suggested to be ‘neurites’ by cultured
neuronal cells and COS-7 cells [11]. The true identity of
these membrane protrusions, a description of their composition,
dynamics and relationship to neurites, which are formed in cells
overexpressing LPR3/PRG1 through apparently LPA-dependent
processes, needs to be established. Because overexpression of
LPR1/PRG3 does not result in increases in rates of dephos-
phorylation of exogenously provided LPA [11,12], these obser-
vations imply that overexpression of LPR1/PRG3 can induce
changes in cell morphology through processes that do not involve
attenuation of LPA signalling, as was suggested for LPR3/
PRG1. Taken together, these studies show that two members
of the LPR/PRG family have a role in regulation of cellular
morphology. However, the mechanistic basis for this surprising
activity is presently not known. In light of their primary sequence
and inactivity in properly controlled experiments, the most
parsimonious conclusion is that none of the LPR/PRG proteins
have intrinsic lipid phosphatase or phosphotransferase activity
which raises the question of whether they are enzymes at all. As
has been found for other classes of protein and lipid phosphatases,
an intriguing possibility is that the LPR/PRG proteins are ‘non-
enzymes’ – catalytically incompetent homologues of active en-
zymes lacking residues critical for catalysis, but retaining residues
required for the capacity to interact non-productively with their
lipid substrates [86]. For example, enzymatically inactive homo-
logues of the phosphoinositide phosphatase, myotubularin, can
still bind D-3 phosphorylated inositol lipids and function as
adapter proteins [87]. Although the identified G-protein-coupled
LPA receptors clearly account for may of the identified signalling
actions of LPA, genetic and pharmacological data imply that
additional mechanisms of LPA signalling exist [88]. Perhaps the
LPR/PRG proteins can interact with LPA, S1P or a related lipid-
signalling molecule and have ‘receptor-like’ activities that are
coupled to pathways that regulate cell morphology? Whatever the




The final group of LPT family proteins contains two members.
These proteins have been provisionally termed CSS2s [9], but,
aside from a report that they do not exhibit SMS activity when
overexpressed in yeast, their enzymatic activities are unexplored.
One of these proteins, CSS2α contains a completely conserved
phosphatase motif that is identical with that found in the LPPs,
which strongly suggests that it may be a functional phosphatase.
CSS2β contains a variant phosphatase motif that is, in some
respects, similar to the apparently inactive phosphatase motif
found in the LPR/PRG proteins. Clearly, the potential enzymatic
activities of these proteins need to be investigated directly. In
comparison with other LPT family members, the defining shared
structural characteristic of the CSS2 proteins is an extended N-
terminus preceding the first transmembrane domain. This region
is approx. 80 amino acids long and quite divergent between the
two proteins, although a short motif close to the transmembrane
domain is well conserved. Hydropathy analysis of these proteins
also predicts the presence of six transmembrane α-helices,
although it is noteworthy that the putative extramembrane loop
sequence between helices 4 and 5 is very short, suggesting that
these two helices may not span the plasma membrane completely,
perhaps forming a single ‘half-membrane-spanning’ helix, as has
been observed in some aquaporin family channel proteins [89].
Expression, localization and functions
Analysis of EST abundance reveals that CSS2β is widely ex-
pressed in mammalian tissues, whereas CSS2α has a more re-
stricted expression pattern (Table 1). Intriguingly, a subtractive
proteomic screen suggests that CSS2β localizes, at least partially,
to the nuclear envelope [90]. The strategy used to isolate proteins
for sequencing in this study implies that CSS2β is at least partially
resistant to extraction of the nuclear membrane with non-ionic
detergents, suggesting that nuclear envelope localization and
retention of the protein involves an interaction with a component
of the nuclear lamina or matrix. The nuclear envelope proteins
sequenced in this screen were obtained from liver which appears
to only express CSS2β (Table 1), therefore clearly the subcellular
localization of both CSS2α and CSS2β needs to be evaluated
directly. The apparent nuclear envelope localization of at least
one of the CSS2 proteins is provocative, because, although LPP
activity has not been explored explicitly in isolated nuclei, both
direct and indirect biochemical observations of enzyme activities
that can generate DG from PA in nuclei have been reported
[91,92]. A growing body of work identifies roles for glycerophos-
pholipids in both the nuclear matrix and surrounding membrane
as regulators of aspects of nuclear function that include signal
transduction and regulation of nuclear RNA export [93]. The
possibility that one or both of the CSS2 proteins functions in
nuclear phospholipid metabolism linked to control of these, and
possibly other nuclear functions, is worth considering.
CONCLUDING COMMENTS
Figure 5 summarizes ideas presented in this review about the
subcellular localization and possible functions of the different
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Figure 5 Subcellular localization and functions of LPT family members
The localization of the CSS2 proteins to the nuclear envelope is speculative and on the basis of results obtained from a subtractive proteomic screen conducted using rat and mouse liver-derived
subcellular fractions. The subcellular localizations of other LPT family members are based on published reports that, for the most part, involve studies using overexpressed epitope-tagged proteins.
C, ceramide; S, sphingosine.
classes of LPT proteins. It is important to stress that the infor-
mation presented in Figure 5 comes from a relatively small
number of studies conducted using divergent cell types and relying
to a great extent on overexpression approaches. Moreover, some
of the ideas presented, in particular about the localization and
functions of the LPR/PRG and CSS2 proteins are admittedly
speculative, but incorporate what limited information is pres-
ently available. Nevertheless, the observations and ideas brought
together in this Figure suggest roles for members of the LPT
family in aspects of lipid metabolism and signalling that involve
all major endomembrane systems of the cell. The advances dis-
cussed in this review promise to stimulate the application of
more sophisticated approaches to the analysis of the function
of the LPT family proteins in cells and animals. Investigators now
have molecular tools to examine the phenotypic consequences
of down-regulation and overexpression of these proteins, and
can employ genetic and mutational approaches to dissect the
structural basis for their activities. As integral membrane proteins,
segregation and sorting of LPT family members to different
membrane compartments is clearly of great importance for under-
standing their cellular functions, and this issue can now be
explored by the construction and analysis of epitope-tagged
variants of the proteins. In particular, members of the LPP, SPP
and SMS families are highly amenable to C-terminal tagging
with green fluorescent protein, which can be used to investigate
their localization and trafficking in live cells. Although many
important questions can now be addressed using cell culture
systems, analysis of LPT family gene function at the organismal
level is now possible. The use of knock-out technology to probe
the function of LPT family members in multicultural organisms is
at a very early stage. The lessons learned from the work on murine
LPP2 and LPP3 and the Drosophila wunen genes indicate that,
although there is may be some functional redundancy between
members within a particular class of LPT proteins, this is likely to
continue to be a very fruitful and productive approach. These gene
inactivation approaches would benefit from the identification of
homologues in simpler genetically manipulatable organisms, and
this is would be another fruitful avenue for functional analysis of
members of the LPT family. As noted in the relevant sections of
this review, budding yeast has been a very important system for
studies of the LPP and SPP enzymes and for the identification of
animal SMSs, whereas studies in Drosophila continue to provide
the most valuable insights into LPP function during early develop-
ment. In this regard, we note that homologues of the two most
interesting and underexplored members of the LPT family, the
LPR/PRG and CSS2 proteins, are restricted to multicellular
organisms, including Drosophila and Caenorhabditis elegans,
which might indicate a role in some aspect of cellular
communication. Finally, as noted at the very beginning of
this article, enzymatic analysis of these enzymes necessarily
involves studies using exogenously provided substrates presented
in unnatural physical forms. The development of assay systems,
for example, using fluorescent substrates as reporters, to monitor
enzyme activity in intact cells or tissues would allow researchers
to evaluate LPT activity in situ.
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